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1. Classification and environmental distribution of Proteus rods 
The genus Proteus, which was described 
for the first time by Hauser in 1885, belongs 
to the Enterobacteriaceae family. In this 
family it is placed in the tribe Proteeae, 
together with the genera Morganella and 
Providencia. Proteus rods are distinguishable 
from most other genera by their ability to 
swarm across agar surfaces of solid media. 
The differentiation of Proteus rods according 
to the results of biochemical tests is shown in 
Proteus sp. – an opportunistic bacterial pathogen – classification, swarming 
growth, clinical significance and virulence factors  
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ABSTRACT 
The genus Proteus belongs to the Enterobacteriaceae family, where it is placed in the 
tribe Proteeae, together with the genera Morganella and Providencia. Currently, the 
genus Proteus consists of five species: P. mirabilis, P. vulgaris, P. penneri, P. hauseri 
and P. myxofaciens, as well as three unnamed Proteus genomospecies. The most 
defining characteristic of Proteus bacteria is a swarming phenomenon, a multicellular 
differentiation process of short rods to elongated swarmer cells. It allows population of 
bacteria to migrate on solid surface. Proteus bacteria inhabit the environment and are 
also present in the intestines of humans and animals. These microorganisms under 
favorable conditions cause a number of infections including urinary tract infections 
(UTIs), wound infections, meningitis in neonates or infants and rheumatoid arthritis. 
Therefore, Proteus is known as a bacterial opportunistic pathogen. It causes 
complicated UTIs with a higher frequency, compared to other uropathogens. Proteus 
infections are accompanied by a formation of urinary stones, containing struvite and 
carbonate apatite. The virulence of Proteus rods has been related to several factors 
including fimbriae, flagella, enzymes (urease - hydrolyzing urea to CO2 and NH3, 
proteases degrading antibodies, tissue matrix proteins and proteins of the complement 
system), iron acqusition systems and toxins: hemolysins, Proteus toxin agglutinin 
(Pta), as well as an endotoxin - lipopolysaccharide (LPS). Proteus rods form biofilm, 
particularly on the surface of urinary catheters, which can lead to serious consequences 
for patients. In this review we present factors involved in the regulation of swarming 
phenomenon, discuss the role of particular pathogenic features of Proteus spp., 
and characterize biofilm formation by these bacteria. 
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the table 1. The genus Proteus currently 
consists of five species: P. mirabilis, 
P. vulgaris, P. penneri, P. hauseri and 
P. myxofaciens, as well as three unnamed 
Proteus genomospecies. Proteus myxofaciens 
is the only Proteus species without any 
significance in the pathogenicity of humans, it 
has been isolated from living and dead larvae 
of the gypsy moth Porteria dispar (O’HARA 
et al. 2000, JANDA & ABBOT 2006). Recently 
described results of the analysis of partial 
sequences of the rpoB gene encoding the 
β-subunit of RNA polymerase, led to the 
conclusion that a genus-level genetic distance 
exists between P. myxofaciens and the species 
of the Proteus-Providencia group. 
Classification of P. myxofaciens in a new 
genus Cosenzaea gen. nov. has therefore been 
proposed (GIAMMANCO et al. 2011). 
 
TABLE 1. Biochemical tests used in differentiation within the genus Proteus (RÓŻALSKI & STĄCZEK 2010, 2011). 
+ 90–100 % positive, - 0 – 9.9 % positive; S – susceptible, R – resistant, V – variable.  
Test P. mirabilis P. vulgaris P. penneri P. hauseri P. myxofaciens 
Salicin fermentation - + - - - 
Maltose fermentation - + + + + 
D-Xylose fermentation + + + + - 
Esculin hydrolysis - + - - - 
Ornithine 
decarboxylase 
+ - - - - 
Indole production - + - + - 
Chloramphenicol 
susceptibility 
S V R S S 
 
Proteus microorganisms are widely 
distributed in the natural environment, 
including polluted water, soil, and manure. 
Due to their proteolytic activity, the ability to 
hydrolyze urea to ammonia and carbon 
dioxide, as well as the oxidative deamination 
of amino acids, these bacteria are involved in 
the decomposing of the organic matter of the 
animal origin. They are also present in the 
intestines of humans and animals. P. mirabilis 
was most frequently isolated from dogs, cows 
and birds, whereas P. vulgaris was most 
frequently isolated from pigs and cold-
blooded vertebrates (JANDA & ABBOT 2006). 
2. Swarming phenomenon 
Swarming is a multicellular differentiation 
phenomenon that allows a population of 
bacteria to migrate on a solid surface in a 
coordinate manner. It is important in 
movement of Proteus rods to new locations 
and most probably helps them in the 
colonization macroorganisms. It involves cell-
to-cell signaling and multicellular interactions 
and is connected with the possibility of 
morphological differentiation of bacteria 
depending on growth media. Proteus are 
dimorphic bacteria, which in liquid media are 
motile, peritrichously flagellated short rods 
(1.0 to 2.0 m in length with 6–10 flagella). 
These bacteria are called swimmer cells. 
However, when transferred onto solid media 
these short rods change into elongated (20–80 
m in length), hyperflagellated, 
multinucleated, nonseptated swarmer cells. 
The latter migrate out from the inoculation 
site as long as the population of swarmer cells 
is reduced on solid surfaces. Then, the 
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consolidation process takes place. In this 
period of swarming growth, the long rods 
disintegrate to short bacteria. The processes of 
differentiation and dedifferentiation of 
Proteus bacteria are cyclic. It results in the 
formation of characteristic rings of bacterial 
growth on the agar plate (fig. 1) 
(VERSTRAETEN et al. 2008, MORGENSTEIN et 
al. 2010, RÓŻALSKI & STĄCZEK 2010).  
Differentiation of swimmer cells into 
swarmer cells is induced by the contact of 
bacteria with a solid surface and the inhibition 
of flagellar rotation. It was found that the 
addition of thickening agents to liquid media 
resulted in differentiation of short rods to 
swarmer cells. A similar effect was obtained 
when antiflagellar antibodies were added to 
liquid medium (BELAS & SUVANASUTHI 
2005). Mutations in gene flaA encoding 
flagellin, as well in genes involved in 
flagellum assembly led to the inhibition of 
Proteus short rods differentiation (BELAS 
1994). Lipopolysaccharide (LPS), a surface 
component of these bacteria, seems to be 
important in the swarming phenomenon, 
however, its exact role has not been 
described. Mutation in the wzz region 
encoding O-antigen chain, as well as in genes 
waaD and waaC required for the core region 
of LPS are impaired in swarming growth 
(MORGENSTEIN et al. 2010). Swarmer cells 
translocation is facilitated by an extracellular 
acidic polysaccharide designated as Cmf 
(colony migration factor), which acts as a 
lubricant, reducing surface friction (GYGI et 
al. 1995). This capsular polysaccharide is 
structurally identical with the O-specific part 
of Proteus LPS serogroup O6 (KNIREL et al. 
2011). Most likely, Proteus O-specific 
polysaccharides are important for the 
swarming. It was found that the Re mutant of 
P. mirabilis R45 producing LPS having only 
the lipid A and Kdo region was unable to 
swarm. The Ra mutant of P. mirabilis R110 
containing lipid A and a complete core region 
expressed only a limited ability for migration 
on the solid medium, whereas most of 
S-forms of P. mirabilis, P. vulgaris and 
P. penneri could swarm vigorously (BABICKA 
2001, KWIL 2003). 
 
 
 
Figure 1. Swarming growth of three strains P. mirabilis strains 34/57 (A), 14/57 (B) and 26/57 (C) on a agar plate 
(KWIL data not published). 
 
Swarming growth is characteristic for 
population of bacteria, thus it is dependent on 
multicellular interactions and cell to cell 
signaling in the phenomenon described as 
quorum sensing. It was found that 
extracellular signal AI-2 (autoinducer-2) does 
not play a role in swarming. Cyclic dipeptides 
were also shown as P. mirabilis signaling 
molecules out of importance in swarming 
(RATHER 2005). Other signal molecules 
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N-acyl homoserine lactones crucial in quorum 
sensing are not produced by P. mirabilis 
(MORGENSTEIN et al. 2010). Nevertheless, it 
was shown that N-acyl homoserine lactones 
added to the media are able to accelerate 
migration of some P. mirabilis strains 
(STAŃKOWSKA et al. 2008). In earlier studies, 
glutamine was found to be able to initiate 
swarming on minimal media (ALLISON et al. 
1993). Swarming growth is also influenced by 
fatty acids. Oleic acid stimulates, whereas 
lauric and myristic acids inhibit this 
phenomenon, respectively (LIAW et al. 2004). 
The mechanism by which glutamine and fatty 
acids play a role in the swarming process as 
signals for cell to cell communication is 
currently unknown. In swarmer cell 
differentiation putrescine was described as a 
biochemical signal, however, the mechanism 
by which this amine regulates swarming is not 
clear. Most probably putrescine can form a 
complex with galacturonic acid which is 
component of CPS. This suggests a possibility 
that putrescine complexed with cell surface 
polysaccharide acts as a signal factor or 
putrescine regulates expression of CPS 
(RATHER 2005, MORGENSTEIN et al. 2010).  
A number of factors playing a role in 
swarming regulations have been recognized 
(DANIELS et al. 2004, RATHER 2005, 
VERSTRAETEN et al. 2008, MORGENSTEIN et 
al. 2010). The most important gene involved 
in upregulation of flagellin production is 
flhDC, class 1 gene of flagellar regulon. This 
gene encodes FlhD2C2 complex, 
a heterotetrameric transcriptional regulator, 
which also regulates the expression of 
additional genes required for swarmer cells 
differentiation. The expression of flhDC 
increases 10-fold during initiation of swarmer 
cells differentiation and it is influenced by 
a variety of environmental factors and 
regulating genes. FlhD2C2 activates class 2 
genes coding basal body and hook proteins of 
flagella, as well as σ28 factor, which activates 
class 3 genes required for synthesis of 
flagellin and flagellum assembly. FlhD2C2 
activity is regulated by two identified factors 
DisA (decarboxylase inhibitor of swarming) 
and Lon protease (ATP-dependent protease). 
DisA most probably inhibits the assembly of 
heterotetramer or its binding to DNA 
(MORGENSTEIN et al. 2010).  
Proteus has 16 predicted two-component 
systems – TCS (PEARSON et al. 2008). TCS 
consists of sensor kinase, which activates 
response regulator DNA – a binding protein 
controlling gene expression. Two of TCS - 
Rcs and Rpp are involved in swarming 
regulation (MORGENSTEIN et al. 2010). Rcs 
system contains RcsC sensor kinase, RcsB 
response regulator, RcsD intermediate 
transferring phosphate to the RcsB and RcsF 
which is an outer membrane lipoprotein. 
Mutation in the genes coding Rcs system in P. 
mirabilis lead to the hyperswarming 
phenotype, most probably due to an increased 
expression of the flhDC. P. mirabilis Rcs 
mutant grows in liquid media as elongated 
cells. The Rpp system consists of RppA 
response regulator and RppB histidine sensor 
kinase like protein. Mutation in the Rpp 
system in P. mirabilis also results in a 
hyperswarming phenotype.  
flhDC expression is also regulated by 
several proteins including Umo, MrpJ, WosA, 
Lrp and RsmA. Umo A-D proteins (umo – 
upregulated expression of the flhDC master 
operon) are located in the cell membrane and 
periplasm. Mutant defective in production of 
UmoD protein is not able to swarm, however, 
such effect was not noticed in the case of 
UmoA and UmoC (DUFOUR et al. 1998).  
mrpJ gene is located in the mrp operon 
encoding MR/P fimbriae, which are required 
for sessile lifestyle of bacteria (NIELUBOWICZ 
& MOBLEY 2010). It is opposite to the 
swimming or swarming phenotype of 
bacteria. The existence of bacteria in one of 
two forms is regulated by mrpJ gene product 
– MrpJ protein, a transcriptional regulator. It 
binds the flhDC promoter, which causes its 
repression and results in loss of motility of 
bacteria (PEARSON & MOBLEY 2008).  
wosA gene coding WosA protein, is 
overexpressed in strains exhibiting 
hyperswarming phenotype (wos – wild type 
onset superswarming). WosA overexpression 
increases the expression of fhlDC and leads to 
a differentiation of swarmer cells in liquid 
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media. The hyperswarming wosA bacteria 
move quickly and spend less time in the 
consolidation phase. wosA expression is 
growth phase dependent, as well as it is 
partially dependent upon the expression of 
flaA gene encoding the flagellar filament 
(HATT & RATHER 2008).  
Leucine responsive protein (Lrp) is a 
transcriptional global regulator involved in 
regulating different processes including amino 
acids synthesis, peptide transport, and pilin 
biogenesis (RATHER 2005, MORGENSTEIN et 
al. 2010). In P. mirabilis strains Lrp plays a 
role in the regulation of the swarming 
phenomenon, most probably its action leads 
to the inhibition of hyperflagellation. 
Mutation in lrp results in a decrease in the 
flhDC, flaA and hpm (hemolysin) expression 
and, in consequence, a nonswarming 
phenotype (HAY et al. 1997). Lrp is well 
known to respond to leucine and to a lesser 
extent to alanine. Recently, it was found that 
it also responds to methionine and is sensitive 
to isoleucine, histidine and thyrosine (HART & 
BLUMENTHAL 2010). In additional studies 
HART et al. (2011) showed that recognition of 
DNA by the helix-turn-helix motif of Lrp is 
modulated by the N-terminal tail.  
RsmA – repressor of secondary 
metabolites is a member of regulatory systems 
involved in the expression control of genes 
which code factors commited to stationary 
growth processes. This protein stabilizes 
mRNA. In P. mirabilis RsmA is 6.8 kDa 
protein containing 62 amino acids. Increasing 
its expression results in the inhibition of 
swarmer cells differentiation and production 
of hemolysin, protease, urease and flagellin 
(LIAW et al. 2003). Overexpressing of rsmA 
led to repression of flhDC (MORGENSTEIN et 
al. 2010).  
The role of the swarming phenomenon in 
the pathogenicity of Proteus bacteria (see 
below) is till now unclear. It was shown that 
swarmer cells demonstrate higher production 
of urease, HpmA hemolysin and IgA 
metaloprotease ZapA, as well as flagellin 
synthesis, as compared to swimmer cells 
(RATHER 2005, JACOBSEN et al. 2008). There 
is some controversy concerning invasiveness 
of swarmer cells. ALLISON et al. 1992 showed 
in vitro that this morphotype could invade 
uroepithelial cells, whereas nonflagellated and 
nonswarming forms were noninvasive. Other 
authors (RÓŻALSKI et al. 1986, CHIPPENDALE 
et al. 1994) showed the short rods as invasive 
forms, rather than swarmer cells. These 
results were confirmed by JANSEN et al. 
(2003) in a mouse model of ascending UTI. 
These authors have found that the 
predominant cell type in the urinary tract are 
short swimmer cells but not elongated 
swarmer cells. Recently, FUJIHARA et al. 
(2011) suggested that P. mirabilis cells 
differentiate into hyperflagellated and 
multinucleated swarmer cells in acidic pH of 
the host’s urine and differentiate back into 
swimmer forms, when the urinary pH is 
increased and it is alkaline after urease action 
(see below). In acidic condition swarmer cells 
exhibit higher cytotoxicity against T24 line. 
In alkaline condition P. mirabilis showed few 
elongated cells with high number of flagella 
and cytotoxic activity.  
 
3. Pathogenicity 
Proteus rods are opportunistic bacterial 
pathogens which under favorable conditions 
cause urinary tract infections (UTIs), wound 
infections, meningitis in neonates or infants 
and rheumatoid arthritis (O’HARA et al. 2000, 
JANDA & ABBOT 2006). KALRA et al. (2011) 
reviewed endocarditis due to Proteus species 
and OKIMOTO et al. (2010) reported 
P. mirabilis pneumonia. Brain abscesses 
during P. vulgaris bacteremia were described 
by BLOCH et al. (2010). However, it should be 
stressed that Proteus bacteria cause UTIs with 
higher frequency. This type of infections is 
classified as uncomplicated or complicated. 
Uncomplicated infections occur in patients 
who are otherwise considered healthy, 
whereas complicated infections usually take 
place in patients with an urinary catheter in 
place or with structural and/or functional 
abnormalities in the urinary tract, suffering 
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from another illness, immunocompromised, as 
well as after surgical intervention in the 
urogenital system. It was found that 
Escherichia coli is a common cause of 
uncomplicated infections. Complicated UTIs 
might be polymicrobial and are usually 
caused by Gram-negative bacteria Proteus 
spp., Providencia stuartii, Morganella 
morganii, E. coli, Pseudomonas aeruginosa, 
Klebsiella pneumoniae as well as some Gram-
positive bacteria (NIELUBOWICZ & MOBLEY 
2010). Proteus rods can cause hematogenous 
infections and ascending infections, however, 
the latter are more common for these 
microorganisms. The ascending infections 
comprise colonization subsequently urethra, 
bladder, ureters and kidneys. P. mirabilis 
causes UTIs with the highest frequency 
among all Proteus species. These bacteria are 
a common cause of complicated UTIs with 
the frequency of 12 % and catheter associated 
bacteriuria (WARREN 1996, JACOBSEN et al. 
2008). They also cause uncomplicated lower 
urinary tract infections, however less 
frequently. CHLABICZ et al. (2011) have found 
in Poland uncomplicated P. mirabilis 
infections with the frequency of 3.4 %.  
The virulence of Proteus rods has been 
related to several factors including fimbriae; 
flagella; enzymes: urease, hydrolyzing urea to 
CO2 and NH3; proteases degrading antibodies, 
tissue matrix proteins and proteins of 
complement system; iron acqusition systems 
and toxins: hemolysins, Proteus toxin 
agglutinin (Pta), as well as endotoxin - 
lipopolysaccharide (LPS) (table 2) (COKER et 
al. 2000, MOBLEY 1996, RÓŻALSKI et al. 
1997, RÓŻALSKI 2002, NIELUBOWICZ & 
MOBLEY 2010). BEVERIDGE (1999) postulated 
the possible role of outer membrane vesicles 
(OMVs) released from the P. mirabilis 
surface, as an alternative route of delivery of 
some enzymes, as well as some virulence 
factors.   
PEARSON et al. (2011) using microarrays 
analyzed P. mirabilis gene expression in vivo 
from experimentally infected mice and 
showed 471 gene upregulated and 82 
downregulated in comparison to the in vitro 
broth culture. Upregulated genes encoded 
among others mannose-resistant Proteus-like 
fimbriae, urease, and iron uptake systems. 
Genes encoding flagella were downregulated. 
Earlier studies (FLANNERY et al. 200) showed 
the identification of 94-kb PAI (pathogenicity 
island) designated ICEPm1 (integrative and 
conjugative elements P. mirabilis 1). This 
PAI is common to P. mirabilis, P. stuartii and 
M. morganii and carries virulence factors 
including Proteus toxic agglutinin (see below) 
and the high pathogenicity island of Yersinia 
spp.  
The P. mirabilis genome predicts 17 
distinct fimbrial operons and 13 additional 
orphan fimbrial genes not associated with 
complete operons (PEARSON et al. 2008, 
NIELUBOWICZ & MOBLEY 2010). The 
biogenesis and/or the biological role were 
studied for six types of fimbriae and 
agglutinins: MR/P (mannose resistant Proteus 
like fimbriae), MR/K (mannose resistant 
Klebsiella hemagglutinins), PMF (Proteus 
mirabilis fimbriae), NAF (nonagglutinating 
fimbriae), ATF (ambient temperature 
fimbriae) and P. mirabilis P-like fimbriae 
(fimbriae, which are similar to E. coli P pili) 
(COKER et al. 2000, ROCHA et al. 2007b, 
JACOBSEN et al. 2008).  
The most important P. mirabilis fimbriae 
seem to be MR/P. This type of fimbriae is 
encoded by mrp operon containing 10 genes 
located on bacterial chromosome. The main 
structural subunit of these fimbriae is the 
MrpA protein. The MrpC protein is an outer 
membrane platform, MrpD plays a role of a 
chaperon protein and MrpH is an adhesin 
located at the fimbrial tip (BAHRANI et al. 
1991, LI et al. 1999, COKER et al. 2000). 
MR/P/ fimbriae undergo phase variation. It 
was found that the MrpI protein acts as 
P. mirabilis recombinase controlling “on/off” 
orientation of the mrp promoter. The fimbrial 
genes are transcribed and MR/P fimbriae are 
synthesized when the promoter is in “on” 
orientation (LI et al. 2002a, NIELUBOWICZ & 
MOBLEY 2010). In the “off” orientation the 
production of fimbriae is stopped. Expression 
of MR/P fimbriae is increased under oxygen 
limitation (LANE et al. 2009). These fimbriae 
contribute to biofilm formation and facilitate 
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colonization of upper urinary tract and were 
found more often on bacterial strains which 
cause pyelonephritis (JANSEN et al. 2004). 
MR/P fimbriae are involved in aggregative 
adherence to HEp-2 cells (ROCHA et al. 
2007a). MR/P fimbriae elicit a strong immune 
response during infection. It is directed 
against the MrpA protein. It was found that 
immunization of mice with the attenuated 
strain of Salmonella Typhimurium expressing 
MrpA-TetC fusion protein led to an increase 
in serum level of IgG antibodies against 
MrpA and significantly reduced P. mirabilis 
colonization of bladder and kidney. TetC is a 
non-toxic highly immunogenic fragment of 
the tetanus toxin (SCAVONE et al. 2011). The 
presence of mrp operon was shown not only 
in P. mirabilis strains but also in other species 
of the Proteus genus (BABICKA 2001, KWIL, 
2002, 2003, KWIL et al. data not published).  
Other than MR/P fimbriae are known to a 
lesser extent. MR/K hemagglutinins were 
found more frequently on P. penneri strains 
than on P. mirabilis strains and most probably 
they facilitated the adherence of bacteria to 
the urinary catheters (JACOBSEN et al. 2008). 
The exact virulence role of PMF fimbriae is 
unclear (NIELUBOWICZ & MOBLEY 2010). 
ZUNINO et al. (2007) by using P. mirabilis 
pmfA/mrpA-D mutant showed the specific and 
additive roles of MR/P and PMF fimbriae in 
UTI caused by these bacteria. NAF fimbriae, 
earlier known as UCA fimbriae, allow 
bacteria to colonize uroepithelial cells (WRAY 
et al. 1986). It was found that NAF/UCA 
binds the following receptors: asialo-GM1, 
asialo-GM3, lactosyl ceramide and galectin 
(LEE et al. 2000, ALTMAN et al. 2001). ATF 
fimbriae are not important in the 
pathogenicity of human beings (ZUNINO et al. 
2000). PMP fimbriae were found on canine 
UTI isolates (BIJLSMA et al. 1995), however 
genes coding this type of fimbriae were found 
in human clinical isolates (PEARSON et al. 
2008).  
There are conflicting results concerning the 
importance of flagella in the infection. Since 
flagella mediate motility of bacteria, they 
seem to be required for virulence of 
uropathogens, particularly during ascending 
infection. Indeed, it was shown in vivo that 
flagella-negative mutant of P. mirabilis is less 
virulent, compared to the wild strain, which 
suggests an important role of these bacterial 
surface structures in the pathogenicity 
(MOBLEY et al. 1996). However, it must be 
stressed, that lack of flagella on P. mirabilis 
human isolate was found (ZUNINO et al. 
1994). Flagella play a role of H antigen and 
are strongly immunogenic. Bacteria can avoid 
immune response of human organism due to 
the antigenic variation process. This 
phenomenon is based on flagellin genes 
rearrangement. Flagellar antigenic variations 
allow bacteria to evade the action of secretory 
IgA antibodies directed against these 
organelles (BELAS 1994).  
P. mirabilis evades the immune system 
response during infection thanks to the 
production of sIgA protease. The best 
characterized is 54-kDa secreted 
metalloprotease ZapA, mirabilysin belonging 
to the serralysin family (LOOMES et al. 1990). 
ZapA possesses a broad spectrum of 
proteolytic specificity, including the activity 
against antibodies of sIgA, IgA2 and IgG, 
proteins of the complement system, cell 
matrix proteins, cytoskeletal proteins, as well 
as antimicrobial defense components of 
human innate system peptides hBD1 and 
cathelicidin LL-37 (BELAS et al. 2004, 
JACOBSEN et al. 2008). ZapA was found to be 
an important virulence factor in a rat model of 
P. mirabilis induced acute and chronic 
prostatitis (PHAN et al. 2008). Recently, 
CARSON et al. (2011) described N-alpha 
mercaptoamide dipeptides, which can be used 
as inhibitors of ZapA. KWIL et al. (2011) have 
shown the presence of the zapA operon in 
P. vulgaris and P. penneri strains.  
It was shown that amino acid deaminase 
(Aad) produces α-keto acids which serves as 
siderophores involved in iron acquisition 
(DRECHSEL et al. 1993, MASSAD et al. 1995). 
Recently, HIMPSI et al. (2010) described 
proteobactin and yersiniabactin related 
siderophore function in P. mirabilis. Zinc, 
another biologically important element 
needed for bacterial growth, is utilized by 
P. mirabilis by use of ZnuABC high affinity 
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transport system (NIELUBOWICZ & MOBLEY 
2010). P. mirabilis also posses high-affinity 
phosphate transporter system Pst. It is 
postulated that this system is important in 
P. mirabilis virulence (JACOBSEN et al. 2008).  
Urease is an urea amidohydrolase which 
catalyses the hydrolysis of urea to ammonia 
and carbamate, then digested to carbone 
dioxide and second molecule of ammonia 
(MOBLEY et al. 1995). This process results in 
elevation of pH and non-physiological 
alkalization of urine, which in turn induces 
the precipitation of magnesium and calcium 
ions, normally soluble in slightly acidic urine, 
and the formation of urinary stones, 
containing struvite and carbonate apatite 
(RÓŻALSKI et al. 1997, JACOBSEN et al. 2008, 
NIELUBOWICZ & MOBLEY 2010). The 
carbonate apatite forms an amorphous 
precipitate opposite to struvite, which forms 
crystals of defined morphology. It was found 
that struvite exhibits polar properties 
(PRYWER & TORZEWSKA 2010, ROMANOWSKI 
et al. 2010). 
 
Table 2. Virulence factors (VP), biological features (BF) and types of growth (TG) of Proteus rods in relation to the 
pathogenicity. 
VP/BF/TG Specific data Contribution to the pathogenicity 
Fimbriae P. mirabilis genome predicts 17 
distinct fimbrial operons. Six types 
of fimbriae/agglutinins were 
identified 
Adherence of bacteria to the epithelial tissue 
Contribution to the biofilm formation  
 
Flagella 
 
H-antigen 
 
Ascension of bacteria in urinary tract. Elicitation 
of immunoresponce which can be avoid due to 
the antigenic variation 
Invassiveness Studied in vitro  Penetration and internalization of bacteria into 
host cells  
Proteases IgA and IgG proteases, which are 
also able to degrade other types of 
biologically important proteins 
Diminish or elimination of phagocytosis  
Amino acid 
deaminase  
Proteobactin and 
yersiniabactin - 
related siderophore 
Production of alpha-keto acids 
which serve as siderophores  
Iron acquisition 
 
ZnuABC 
Pst 
High affinity zinc transport system 
High affinity phosphate transporter  
Zinc utilization 
Phosphate accumulation  
Urease  Enzyme hydrolyzing urea to NH3 
and CO2  
Elevation of urine pH level, resulting in stones 
formation. Cytotoxicity against urinary epithelial 
cells   
Protein toxins: 
HmpA  
HlyA 
Pta 
 
Cell-bound hemolysin 
Cell free hemolysin, RTX protein  
Cytotoxin and agglutinin 
 
Pore forming toxins mediating cytotoxicity 
 
Cytotoxicity and autoagglutination of bacteria 
CPS Most probably structurally identical 
with O-specific part of LPS 
Formation of biofilm. Importance in formation of 
urinary stones. Facilitation of swarmer cells 
translocation 
LPS Endotoxin Endotoxicity. Resistance against bactericidal 
action of the serum. Production of glycocalyx 
important in biofilm formation   
OMVs Outer membrane vesicles containing 
periplasmic constituents 
Transport of virulence factors to the host tissues 
Swarming growth Differentiation of short rods to 
swarmer cells  
Not fully understood 
Biofilm formation  Crystalline biofilm, particularly 
formed on the surface of urinary 
catheters 
Protection of bacteria against action of 
antibiotics and immune mechanisms 
FOLIA BIOLOGICA ET OECOLOGICA 
  
 
 
 
PROTEUS SP. – AN OPPORTUNISTIC BACTERIAL PATHOGEN  9 
 
The structural and elastic properties of 
struvite crystals were studied by PIECHOTA et 
al. (2011). Formation and morphology of 
struvite crystals depend on the pH of urine. 
PRYWER and TORZEWSKA (2009) have found 
that for pH in the range 7.5–9.0 struvite 
crystals take single and hemimorphic 
morphology. At higher pH many twin and 
dendritic crystals have been shown. 
DUMANSKI et al. (1994) has revealed that 
Proteus capsular polysaccharide structurally 
identical to O-specific polysaccharide of LPS 
accelerates crystallization process. 
TORZEWSKA et al. (2003) confirmed this 
observations and showed that urinary stone 
formation due to the urease activity, may be 
modified by surface O-antigens being a part 
of lipopolysaccharides (LPS). The sugar 
composition of these polysaccharides may 
either enhance or inhibit the crystallization of 
struvite and carbone apatite depending on 
their chemical structure and ability to bind 
cations. Bacteria present within urinary stones 
are protected from host defense mechanisms 
and antibiotic treatment (LI et al. 2002b). 
Therefore, several phytotherapeutic 
compounds have been investigated to prevent 
urinary stone formation. For example 
curcumin an yellow-orange pigment non toxic 
to humans or animals extracted from the roots 
of turmeric (Curcuma longa) was shown to 
inhibit urease activity and consequently 
decrease the struvite growth. It was found in 
vitro experiment of struvite formation in 
artificial urine that the addition of curcumin 
increases the induction time and decreases the 
efficiency of formation of these crystals 
(TORZEWSKA et al. 2010, PRYWER & 
TORZEWSKA 2010, 2012). Moreover, 
curcumin also inhibits biofilm formation and 
block swarming growth (TORZEWSKA et al. 
2010). Recently, MALIC et al. (2011) reported 
on the development of an early warning 
sensor for encrustation of urinary catheters in 
case of Proteus infection.  
It was shown that the high level of 
ammonia, a product of urease action also 
results in damage of the urinary tract 
epithelium. Toxic ammonia damages bladder 
surface glycosaminoglycans important in the 
prevention of bacterial adherence to the 
uroepithelium (JACOBSEN et al. 2008). In vitro 
studies performed by TORZEWSKA and 
RÓŻALSKI (2009) showed that 
glycosaminoglycans have no inhibitory effect 
on infection-induced crystallization.  
In a mouse model of ascending UTI it was 
found that the urease negative mutant of P. 
mirabilis was less virulent as compared to the 
wild strains, which suggests the important 
role of this enzyme in infection caused by this 
bacterium (JONES et al. 1990). Therefore, 
investigation of different substances which 
can be used as urease inhibitors is being 
performed. Recently, BERLICKI et al. (2011) 
described N-substituted amino-methane-
phosphonic and aminomethane-P-
methylphosphonic acids as effective inhibitors 
of P. mirabilis urease.  
Proteus rods produce three types of 
cytolysins, HpmA and HlyA hemolysins and 
Pta cytotoxic agglutinin. HpmA is the 166 
kDa protein, calcium–independent cell-bound 
hemolysin secreted by the bacteria and 
activated in the process mediated by HpmB 
(UPHOFF & WELCH 1990). This hemolysin 
belongs to the pore forming toxins family and 
it is cytotoxic against a number of cells 
(SWIHART & WELCH 1990). HlyA hemolysin 
is produced by P. vulgaris, P. penneri and 
P. hauseri strains (KORONAKIS et al. 1987, 
RÓŻALSKI & KOTEŁKO 1987, RÓŻALSKI & 
STĄCZEK 2011). It is a strongly cytotoxic, 
calcium dependent 110 kDa extracellular 
toxin belonging to the RTX family of proteins 
(RTX - repeat in toxin). Pta (Proteus toxic 
agglutinin), an autotransporter with subtilase-
like serine protease activity exhibits 
bifunctional activity. It is both cytotoxin and 
agglutinin, which mediates autoagglutination 
of bacteria and cytotoxicity against human 
bladder and kidney cells. The vaccination of 
mice with Pta results in protection against 
P. mirabilis UTI (ALAMURI & MOBLEY 2008).  
Lipopolysaccharide is composed of three 
genetically and structurally distinct regions: 
O-specific chain (O-antigen, O-specific 
polysaccharide), the core oligosaccharide and 
lipid A, which anchors the LPS molecule to 
the bacterial outer membrane (RAETZ & 
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WHITFIELD 2002). LPS containing all these 
three regions is produced by smooth forms of 
bacteria. Rough strains synthesize LPS 
containing lipid A and the whole core region 
or only its part. All three regions of Proteus 
LPS have been studied (RÓŻALSKI 2002, 
2004, 2008, RÓŻALSKI et al. 2002). The 
differences in the structure of O-antigens 
serve as a basis for the serological 
classification of Proteus strains. The 
serological classification scheme currently 
consists of 78 serogroups (DRZEWIECKA et al. 
2004, 2008, 2010, DRZEWIECKA & 
SIDORCZYK 2005, KNIREL et al. 2011). The 
prevalence of particular Proteus O-serogroups 
among clinical isolates has been changing 
over the time. Previously, clinical isolates 
were found to belong to serogroups O3, O10, 
O11, O13, O23, O27 and O30. Recently, 
KACA et al. (2011) studying 123 clinical 
isolates from Sweden and Poland showed that 
none of serogroups was predominant. 
DRZEWIECKA et al. 2010 described seven 
P. mirabilis strains representing serogroup 
O78 which can be classified in one bacterial 
clone widespread in hospitals, most probably 
due to the nosocomial infection and 
autoinfections. The results of detailed studies 
of Proteus O-specific polysaccharides are 
presented in the review by KNIREL et al. 2011. 
WANG et al. (2010) identified five putative 
Proteus O-antigen gene clusters and Proteus 
specific genes of strains classified to five 
serogroups.  
 
Figure 2. Structure of the O-specific repeating unit (A) and core oligosaccharide obtained by mild acid degradation 
(B) of lipopolysaccharide of Proteus mirabilis genomic strain HI 4320. Alt - altruronic acid (KNIREL et al. 2011, 
VINOGRADOV 2011). 
The core region of Proteus 
lipopolysaccharides was studied by use of 
rough mutants or smooth forms classified into 
different serogroups (RADZIEJEWSKA-
LEBRECHT et al. 1989, VINOGRADOV et al. 
1994, VINOGRADOV et al. 2002). The 
structural diversity of the core is characteristic 
for Proteus spp. and makes it different from 
E. coli and Salmonella (HOLST 1999, 
VINOGRADOV et al. 2002). The Proteus core 
region is composed of two parts – an inner 
part, common for several number of strains 
and second, an outer part, which is 
characterized by structural variability from 
strain to strain. The common part is not 
identical in all Proteus strains and is 
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subdivided into three forms known as 
glycoforms I-III. The outer part of the core 
region (outer core) contains an 
oligosaccharide characteristic for particular 
Proteus strains (VINOGRADOV et. al 2002, 
RÓŻALSKI 2008). The structure of the core 
part of P. mirabilis genomic strain HI4320 
(formerly classified into serogroup O10) was 
shown by VINOGRADOV (2011) (fig. 2). The 
epitope specificity of the core region of 
P. penneri strains were studied by PALUSIAK 
and SIDORCZYK (2010). They have identified 
seven epitopes responsible for cross reactivity 
of LPS of these bacteria with appropriate 
antisera. The identification of genes required 
for the biosynthesis of the core region of 
P. mirabilis were described by AQUILINI et al. 
(2010).  
LPS, released from pathogenic bacteria 
during infection induces a spectrum of 
biological activities. Therefore, LPS is also 
known as an endotoxin. The mechanism of 
biological action of the endotoxin is common 
to most bacteria. Its biological domain is 
lipid A (ŁUKASIEWICZ & ŁUGOWSKI 2003). 
Proteus lipid A contains glucosamine 
disaccharide substituted with phosphate 
residues and fatty acids. It also contains 
4-amino-4-deoxy-L-arabinopyranose 
(L-Arap4N), which quantitatively substitutes 
the ester-linked phosphate residue of the 
glucosamine backbone (SIDORCZYK et al. 
1983).  
Proteus LPS is associated with a broad 
spectrum of biological activities, and with 
interactions with bacterial or eukaryotic cells 
(RÓŻALSKI 2008). LPS of S-forms of bacteria 
contributes to their resistance against 
bactericidal action of the serum (KACA & 
UJAZDA 1998, MIELNIK et al. 2004, BABICKA 
2001, KWIL 2003, KACA et al. 2009). The O-
specific polysaccharide chain exposed outside 
bacteria is involved in glycocalyx formation. 
Glycocalyx enables bacteria to grow in a form 
of biofilm on a solid surface. 
Bacterial biofilm is defined as a matrix-
enclosed bacterial population adhering to the 
surfaces. Bacteria enclosed in a glycocalyx 
capsule are protected against the action of 
antibodies, as well as against other immune 
mechanisms (DONLAN & COSTERTON 2002, 
STICKLER & FENLEY 2010). Proteus bacteria 
form a crystalline biofilm particularly on the 
surface of catheters (STICKLER 2008). It 
contains calcium phosphate and magnesium 
phosphate crystals formed due to the action of 
urease. JONES et al. (2007) reported that the 
structure of P. mirabilis biofilm depends on 
the environment (artificial urine, laboratory 
media) in which it occurs. Biofilms in Luria-
Bertani (LB) broth formed a mushroom-like 
architecture, while biofilms grown in urine 
formed a flat layer. MORYL et al. (2008) 
studied the effect of environmental factors 
such as glucose, acidic pH, albumin and some 
antimicrobial agents: ciprofloxacin and 
methylene blue on the formation of 
P. mirabilis biofilm. The most inhibiting 
effect was observed after incubation of 
bacteria with albumin and in acidic growth 
media. KWIECINSKA-PIRÓG (2010) studied the 
formation of biofilm on different surfaces, 
and has found silicone latex surface to be 
better than polychloride vinyl and 
polypropylene surfaces for P. mirabilis 
growth in biofilm. Octenisept R an antiseptic 
products occured to be active against these 
bacteria growing in biofilm. Prevention and 
eradication of P. mirabilis biofilm by use of 
lytic bacteriophages was shown by CARSON et 
al. (2010). It was also found that two quorum 
sensing antagonists p-nitrophenyl glycerol 
(PNPG) and tannic acid inhibit the formation 
of P. mirabilis biofilm in artificial urine 
(JONES et al. 2009). P. mirabilis biofilm 
formation on glass and polystyrene can also 
be inhibited by extract of Ibucella lutea, a 
native plant of America (SOSA & ZUNINO 
2009). MORYL (2010) observed inhibition of 
biofilm formation by P. mirabilis growing 
together with Escherichia coli or Providencia 
stuartii. STAŃKOWSKA et al. (2011) showed a 
significant influence of N-butanoyl 
homoserine lactone (BHL) on biofilm 
formation by P. mirabilis strain belonging to 
serogroup O18. Recently, SCHLAPP et al. 
(2011) excluded the contribution of swarmer 
cells in biofilm formation during the 7-day 
incubation of bacteria in LB broth on glass 
coverslips. These authors showed that  
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P. mirabilis biofilm formation is a five-stage 
process: i) reversible adhesion to the solid 
surface with slow growth of bacteria, 
presence of elongated cells and absence of 
extracellular matrix, ii) irreversible bacterial 
adhesion, beginning of production of 
extracellular materials and decreasing of 
elongation, iii) acceleration of bacterial 
growth, further decrease in elongation and 
halting production of extracellular material, 
iv) maturation of biofilm, v) detachment of 
bacterial cells and dispersion of biofilm. 
4. Summary 
Proteus bacteria inhabit the environment 
and they are also present in the intestines of 
humans and animals. These microorganisms 
under favorable conditions cause a number of 
infections including urinary tract infections 
(UTIs), wound infections, meningitis in 
neonates or infants and rheumatoid arthritis. 
Proteus opportunistic pathogens express 
virulence factors associated with adherence, 
motility, immunoavoidance, nutrient 
acquisition, host damage, biofilm formation 
and endotoxicity. The most defining 
characteristics of Proteus bacteria is the 
swarming phenomenon, a multicellular 
differentiation process of short rods to 
elongated swarmer cells. It allows the 
population of bacteria to migrate in a 
coordinate manner on a solid surface. The role 
of short rods and elongated swarmer cells in 
the pathogenicity of Proteus bacteria is still 
not established. The elongated morphotype 
seems to be in the minority during infection. 
Proteus bacteria form a crystalline biofilm, 
particularly on the surface of catheters present 
in the urinary tract of patients. It contains 
struvite and hydroxyapatite crystals formed 
due to the action of urease. The results of the 
study on Proteus virulence and fitness factors 
will lead to a better understanding of 
infectious processes and will subsequently 
allow developing new methods of prevention 
and clinical treatment. 
 
5. References 
ALAMURI, P., MOBLEY, H.L.T. 2008. A novel 
autotransporter of uropathogenic Proteus mirabilis 
is both a cytotoxin and an agglutinin. Mol. 
Microbiol. 68: 997–1017.  
ALLISON, C., COLEMAN, N., JONES, P.L., HUGES, C. 
1992. Ability of Proteus mirabilis to invade 
urothelial cells is coupled to motility and swarming 
differentiation. Infect. Immun. 60: 4740–4746. 
ALLISON, C., LAI, H.C., HUGHES, C. 1993. Cell 
differentiation of Proteus mirabilis is initiated by 
glutamine, a specific chemoattractant for swarming 
cells. Mol. Microbiol. 8: 53–60. 
ALTMAN, E., HARRISON, B.A., LATTA, R.K., LEE, K.K., 
KELLY, J.F., TIMBAULT, P. 2001. Galectin-3-
mediated adherence of Proteus mirabilis to Madin-
Darby canine kidney cells. Biochem. Cell. Biol. 79: 
783–788.  
AQULIINI, E., AZEVEDO, J., JIMENEZ, N., BOUAMAMA, 
L., TOMAS, J.M., REGUE, M. 2010. Functional 
identification of the Proteus mirabilis core 
lipopolysaccharide biosynthetic genes. J. Bacteriol. 
192: 4413–4424. 
BABICKA, D. 2001. Investigations of serological 
specificity of O-antigens of Proteus vulgaris O1, 
O2, O4 and O9 and selected biological features of 
this species. Ph.D. thesis. University of Lodz. (In 
Polish). 
BAHRANI, F.K., JOHNSON, D.E., ROBBINS, D. M., 
MOBLEY, H.L.T. 1991. Proteus mirabilis flagella 
and MR/P fimbriae: isolation, purification, N-
terminal analysis, and serum antibody response 
following urinary tract infection. Infect. Immun. 59: 
3574–3480.   
BELAS, R. 1994. Expression of multiple flagellin-
encoding genes of Proteus mirabilis. J. Bacteriol., 
176: 7169–7181.  
BELAS, R., MANOS, J., SUVANASUTHI, R. 2004.  Proteus 
mirabilis ZapA metalloprotease degrades a broad 
spectrum of substrates, including antimicrobial 
peptides. Infect. Immun.72: 5159–5167. 
BELAS, R., SUVANASUTHI, R. 2005. The ability of 
Proteus mirabilis to sense surfaces and regulate 
virulence gene expression involves FliL, a flagellar 
basal body protein. J. Bacteriol. 187: 6789–6803. 
BERLICKI, L., BOCHNO, M., GRABOWIECKA, A., 
BIAŁAS, A., KOSIKOWSKA, P., KAFARSKI, P. 2011. 
N-substituted aminomethanephosphonic and 
aminomethane-P-methylphosphinic acids as 
inhibitors of ureases. Amino Acids. DOI: 
10.1007/s00726-011-0920-4. 
FOLIA BIOLOGICA ET OECOLOGICA 
 
 
 
PROTEUS SP. – AN OPPORTUNISTIC BACTERIAL PATHOGEN  13 
 
BEVERIDGE, T.J. 1999. Structures of Gram-negative 
cell walls and their derived membrane vesicles. J. 
Bacteriol. 181: 4725–4733. 
BIJLSMA, I.G., VAN DIJK, L., KUSTERS, J.G., GAASTRA, 
W. 1995. Nucleotide sequence of two fimbrial 
subunit genes, pmpA and ucaA from canine -
uropathogenic Proteus mirabilis strains. 
Microbiology. 141: 1349–1357. 
BLOCH, J., LEMAIRE, X., LEGOUT, L., FERRIBY, D., 
YAZDANPANAH, Y., SENNEVILLE, E. 2010. Brain 
abscesses during Proteus vulgaris bacteremia. 
Neurol. Sci. 32: 661–663.  
CARSON, L., CATHCART, G.R., SCOTT, C.J., 
HOLLENBERG, M.D., WALKER, B., CERI, H., 
GILMORE B.F. 2011 Comprehensive inhibitory 
profiling of the Proteus mirabilis metalloprotease 
virulence factor ZapA (mirabilysin). Biochemie. 
93:1824–1827.  
CARSON, L., GORMAN, S.P., GILMORE, BF. 2010. The 
use of lytic bacteriophages in the prevention and 
eradication of biofilms of Proteus mirabilis and 
Escherichia coli. FEMS Immunol. Med. Microbiol. 
59: 447–455.  
CHIPPENDALE, G.R., WARREN, J.W., TRIFILLIS, A.L., 
MOBLEY, H.L.T. 1994. Internalization of Proteus 
mirabilis by human renal epithelial cells. Infect. 
Immun. 62: 3115–3121. 
CHLABICZ, S., LESZCZYŃSKA, K., LUKAS, W., GUALCO, 
L., SCHITO, G., NABER, K.G. 2011. Uncomplictaed 
lower urinary tract infections in females-clinical 
aspects, aetiology and antimicrobial resistance 
epidemiology. Results of the ARESC 
(Antimicrobial Resistance Epidemiological Survey 
on Cystitis) study in Poland on their implications 
for empiric therapy. Przegl. Epidemiol. 65: 345–
351. (In Polish).   
COKER, C., POORE A., LI, X., MOBLEY, H.L.T. 2000. 
Pathogenesis of Proteus mirabilis urinary tract 
infections. Microb. Infect. 2: 1497–1505. 
DANIELS, R., VANDERLEYDEN, J., MICHIELS, J. 2004. 
Quorum sensing and swarming migration in 
bacteria. FEMS Microbiol. Rev. 28: 261–289. 
DONLAN, R.M., COSTERTON, J.W. 2002. Biofilms: 
survival mechanism of clinically relevant 
microorganisms. Clin. Microbiol. Rev. 15: 167–
193.  
DOUFOUR, A., FURNESS, R.B., HUGHES, C. 1998. Novel 
genes that upregulate the Proteus mirabilis flhDC 
master operon controlling flagellar biogenesis and 
swarming. Mol. Microbiol. 29: 741–751. 
DRECHSEL, H.A., THIECKEN, A., REISSBRODT, R., JUNG, 
G., WINKELMANN, G. 1993. -keto acids are novel 
siderophores in the genera Proteus, Providencia 
and Morganella and are produced by amino acid 
deaminases. J. Bacteriol. 175: 2727–2733. 
DRZEWIECKA, D., ARBATSKY, N.P., SHASHKOV, A.S., 
STĄCZEK, P., KNIREL, Y.A., SIDORCZYK, Z. 2008. 
Structure and serological properties of the O-
antigen of two clinical Proteus mirabilis strains 
classified into a new Proteus O77 serogroup. FEMS 
Immunol. Med. Microbiol. 54: 185–194. 
DRZEWIECKA, D., ARBATSKY, N.P., STĄCZEK, P., 
SHASHKOV, A.S., KNIREL, Y.A., SIDORCZYK, Z. 
2010. Structure and serological studies of the O-
polysaccharide of strains from a newly created 
Proteus O78 serogroup prevalent in Polish patients. 
FEMS Immunol. Med. Microbiol. 58: 269–276. 
DRZEWIECKA, D., SIDORCZYK, Z. 2005. 
Characterization of Proteus penneri species – 
human opportunistic pathogens. Post. Mikrobiol. 
44: 113–126. (In Polish).   
DRZEWIECKA, D., ZYCH, K. SIDORCZYK, Z. 2004. 
Characterization and serological classification of a 
collection of Proteus penneri clinical strains. Arch. 
Immunol. Therap. Exp. 52:121–128. 
DUMANSKI, A.J., HEDELIN, H., EDIN-LILJEGREN, A., 
BEACHEMIN, D., MCLEAN, R.J.C. 1994. Unique 
ability of Proteus mirabilis capsule to enhance 
mineral growth in infectious urinary calculi. Infect. 
Immun. 62: 2998–3003. 
FLANNERY, E., MODY, L., MOBLEY, H.L.T. 2009. 
Identification of a modular pathogenicity island that 
is widespread among urease-producing 
uropathogens and shares features with diverse 
group of mobile elements. Infect. Immun. 77: 
4887–4894.  
FUJIHARA, M., OBARA, H., WATANABE, Y., ONO, H.K., 
SASAKI J., GORYO, M., HARASAWA, R. 2011. Acidic 
environments induce differentiation of Proteus 
mirabilis into swarmer morphotypes. Microbiol. 
Immunol. 55: 489–493. 
GIAMMANCO, G.M., GRIMONT, P.A., GRIMONT, F., 
LEFEVRE, M., GIAMMANCO, G., PIGNATO, S. 2011. 
Phylogenic analysis of the genera Proteus, 
Morganella, Providencia by comparison of rpoB 
gene sequence of type and clinical strains suggests 
reclassification of Proteus myxofaciens in a new 
genus, Cosenzaea gen. nov., as Cosenzaea 
myxofaciens comb. nov. Int. J. Syst. Evol. 
Microbiol. 61:1638–1644. 
GYGI, D., RAHMAN, M.M., LAI, H.C., CARLSON, R., 
GUARD-PETTER, J., HUGHES, C. 1995. A cell 
surface polysaccharide that facilitates rapid 
population migration by differentiated swarm cells 
of Proteus mirabilis. Mol. Microbiol. 17: 1167–
1175. 
HART, B.R., BLUMENTHAL, R.M. 2010. Unexpected 
coregulator range in the global regulator Lrp of 
Escherichia coli and Proteus mirabilis. J. Bacteriol. 
193: 1054–1064.   
FOLIA BIOLOGICA ET OECOLOGICA 
RÓŻALSKI  ET AL.  14 
 
HART, B.R., MISHRA, P.K., LINTER, R.E., HINERMAN, 
J.M., HERR, A.B., BLUMENTHAL, R.M. 2011. 
Recognition of DNA by the helix-turn-helix global 
regulatory protein Lrp is modulated by the amino 
terminus. J. Bacteriol. 193:3794–3803.  
HATT, J.K., RATHER, P.N. 2008. Characterization of 
novel gene, wosA, regulating FlhDC expression in 
Proteus mirabilis. J. Bacteriol. 190: 1946–1955.   
HAY, N.A., TIPPER, D., GYGI, D., HUGHES, C. 1997. A 
nonswarming mutant of Proteus mirabilis lacks the 
Lrp global transcriptional regulator. J. Bacteriol. 
179: 4741–4746. 
HIMPSI, S.D., PEARSON, M.M., AREWANG, C.J., NUSCA 
T.D., SHERMAN D.H., MOBLEY, H.L.T. 2010. 
Proteobactin and a yersiniabactin-related 
siderophore mediate iron acquisition in Proteus 
mirabilis. Molec. Microbiol. 78: 138–157.  
HOLST, O. 1999. Chemical structure of the core region 
of lipopolysaccharides. In: H. BRADE, S.M. OPAL, 
S.N. VOGEL, D.C. MORRISON (eds). Endotoxin in 
health and disease. Marcel Dekker, Inc. New York, 
Basel, pp. 115–154. 
JACOBSEN, S.M., STICKLER D.J., MOBLEY, H.L.T., 
SHIRTLIFF, M.E. 2008. Complicated catheter-
associated urinary tract infections due to 
Escherichia coli and Proteus mirabilis. Clin. 
Microbiol. Rev. 21: 26–59. 
JANDA, J.M., ABBOT, S.L. 2006. The 
Enterobacteriaceae. ASM Press. Washington. 233–
259. 
JANSEN, A.M., LOCKATELL, C.V., JOHNSON, D.E., 
MOBLEY, H.L.T. 2004. Mannose-resistant Proteus-
like fimbriae are produced by most Proteus 
mirabilis strains infecting the urinary tract, dictate 
the in vivo localization of bacteria, and contribute to 
biofilm formation. Infect. Immun. 72: 7292–7305.   
JANSEN, B.V., LOCKATELL, C.V., JOHNSON, D.E., 
MOBLEY, H.L.T. 2003. Visualisation of Proteus 
mirabilis morphotypes in the urinary tract: the 
elongated swarmer cell is rarely observed in 
ascending urinary tract infection. Infect. Immun. 
71: 3607–3613. 
JONES, B.D., LOCKATELL, C.V., JOHNSON, D.E., 
WARREN, J.W., MOBLEY, H.L.T. 1990. Construction 
of urease-negative mutant of Proteus mirabilis: 
analysis of virulence in mouse model of ascending 
urinary tract infection. Infect. Immun.  58: 1120–
1123. 
JONES, S.M., YERLY, J., HU, Y., CERI, H., MARTINUZZI, 
R. 2007. Structure of Proteus mirabilis biofilm 
grown in artificial urine and standard laboratory 
media. FEMS Microbiol. Lett. 268:16021.  
JONES, S.M., DANG, T., MARTINUZZI, R. 2009. Use of 
quorum sensing antagonists to deter the formation 
of crystalline Proteus mirabilis biofilm. Int. J. 
Antimicrob. Agen. 34: 360–364.   
KACA, W., ARABSKI, M., FUDAŁA, R., HOLMSTROM, E., 
SJOHOLM, A., WEINTRAUB, A., FUTOMA-KOŁOCH., 
B., BUGLA-PŁOSKOŃSKA, G., DOROSZKIEWICZ, W. 
2009. Human complement activation by smooth 
and rough Proteus mirabilis lipopolysaccharides. 
Arch. Immunol. Ther. Exp. 57: 383–391.  
KACA, W., GLENSKA, J., LACHOWICZ, L., GRABOWSKI, 
S., BRAUNER, A., KWINKOWSKI, M. 2011. 
Serotyping of Proteus mirabilis clinical strains 
based on lipopolysaccharide, O-polysaccharide and 
core oligosaccharide structures. Biochemistry 
(Moscow). 76: 851–861. 
KACA, W., UJAZDA, E. 1998. Complement activation 
by bacterial endotoxin. Post. Mikrobiol. 37: 421–
427. (In Polish). 
KALRA, A., COOLEY, C., TSIGRELIS, C. 2011. Treatment 
of endocarditis due to Proteus species: a literature 
review. Int. J. Infect. Dis. 15: 222–225.  
KNIREL, Y.A., PEREPELOV, A.V., KONDAKOVA, A., 
SENCHEKOVA, S.N., SIDORCZYK, Z., RÓŻALSKI, A., 
KACA, W. 2011. Structure and serology of O-
antigens as the basis for classification of Proteus 
strains. Inn. Immun. 17: 70–96. 
KORONAKIS, V., CROSS, M., SENIOR, B., KORONAKIS, 
E., HUGHES, C. 1987. The secreted hemolysins of 
Proteus mirabilis, Proteus vulgaris, and 
Morganella morganii are genetically related to each 
other and to the alpha-hemolysin of Escherichia 
coli. J. Bacteriol. 169: 1509–1515. 
KWIECIŃSKA-PIRÓG, J. 2010. Estimation of production 
of biofilm by Proteus mirabilis bacilli. Ph.D. thesis. 
Nicolas Copernicus University of Toruń. Collegium 
Medicum in Bydgoszcz. (In Polish).  
KWIL, I., BABICKA, D., STĄCZEK, P., RÓŻALSKI, A. 
2002. Applying the PCR metod for searching genes 
encoding main structural fimbrial proteins. In: 5
th 
Conference on Molecular biology in diagnostics of 
infectious disease and biotechnology. Warsaw, 
SGGW Publisher. 88–91. 
KWIL, I. 2003. Investigations of selected virulence 
factors of Proteus penneri strains. Ph.D. thesis. 
University of Lodz. (In Polish).  
KWIL, I., BIEGAŃSKA, H., OBAREK, K., RÓŻALSKI, A. 
2006. Expression of selected virulence factors 
among new bacterial species from the genus 
Proteus: P. hauseri and Proteus genomospecies 4, 
5, 6. In: 9
th 
Conference on molecular biology in 
diagnostics of infectious disease and biotechnology. 
Warsaw, SGGW Publisher. 93–96. 
LANE, M.C., PEARSON, M.M., SIMMS, A.N., MOBLEY, 
H.L.T. 2009. Oxygen-limiting conditions enrich for 
fimbriate cells of uropathogenic Proteus mirabilis 
and Escherichia coli. J. Bacteriol. 191: 1382–1392.  
FOLIA BIOLOGICA ET OECOLOGICA 
 
 
 
PROTEUS SP. – AN OPPORTUNISTIC BACTERIAL PATHOGEN  15 
 
LEE, K.K., HARRISON, B.A., LATTA, R., ALTMAN, E. 
2000. The binding of Proteus mirabilis 
nonagglutinating fimbriae to ganglio-series 
asialoglycolipids and lactosyl ceramide. Can. J. 
Microbiol. 46: 961–966. 
LI, X., JOHNSON, D.E., MOBLEY, H.L.T. 1999. 
Requirement of MrpH for mannose-resistant 
Proteus-like fimbria- mediated hemagglutination by 
Proteus mirabilis. Infect. Immun. 67: 2822–2833. 
LI, X., LOCKATELL, C.V., JOHNSON, D.E., MOBLEY, 
H.L.T. 2002a. Identification of MrpI as the sole 
recombinase that regulates the phase variation of 
MR/P fimbria, a bladder colonization factor of 
uropathogenic Proteus mirabilis. Mol. Microbiol. 
45: 865–874.   
LI, X., ZHAO, H., LOCKATELL, C.V., DRACHENBERG, 
C.B., JOHNSON, D.E., MOBLEY, H.L.T. 2002b. 
Visualization of Proteus mirabilis within the matrix 
of urease-induced bladder stones during 
experimental urinary tract infection. Infect. Immun. 
70: 389–394. 
LIAW., S.J., LAI, H.C., HO, S.W., LUH, K.T., WANG, 
W.B. 2003. Role of RsmA in the regulation of 
swarming motility and virulence factor expression 
in Proteus mirabilis. J. Med. Microbiol. 52: 19–28.  
LIAW, S.J., LAI, H.C., WANG., W.B. 2004. Modulation 
of swarming and virulence by fatty acids trough the 
RsbA protein in Proteus mirabilis. Infect. Immun. 
72: 6836–6845. 
LOOMES, L.M., SENIOR, B.W., KERR, M.A. 1990. A 
proteolytic enzyme secreted by Proteus mirabilis 
degrades immunoglobulins of the immunoglobulin 
A1 (IgA1), IgA2, and IgG isotypes. Infect. Immun. 
58: 1970–1985. 
ŁUKASIEWICZ, J., ŁUGOWSKI, C. 2003. Biological 
activities of lipopolysaccharide. Post. Hig. Med. 
Doświad. 57: 33–53. (In Polish). 
MALIC, W., WATTERS, M,G., BASIL, L., STICKLER, D.J., 
WILLIAMS, D.M. 2011. Development of an “early 
warning” sensor for encrustation of urinary 
catheters following Proteus infection. J. Biomed. 
Mater Res. B Appl. Biomater. DOI: 
10.1002/jbm.b.31930. 
MASSAD, G., ZHAO, H., MOBLEY, H.L.T. 1995. Proteus 
mirabilis aminoacid deaminase: cloning, nucleotide 
sequence, and characterization of aad. J. Bacteriol. 
177: 5878–5883. 
MIELNIK, G., DOROSZKIEWICZ, W., KORZENIOWSKA–
KOWAL, A. 2004. External structures of Gram-
negative bacteria and bactericidal activity of 
complement. Post. Mikrobiol. 43: 39–57. (In 
Polish). 
MOBLEY, H.L.T. 1996. Virulence of Proteus mirabilis. 
In: H.L.T. MOBLEY, J.W. WARREN (eds.) Urinary 
tract infections, molecular pathogenesis and clinical 
management. ASM Press, Washington DC, pp. 
245–269. 
MOBLEY, H.L.T, BELAS, R., LOCKATELL, V., 
CHIPPENADALE, G., TRIFILLIS A.L., JOHNSON, D.E., 
WARREN, J.W. 1996. Construction of a flagellum-
negative mutant of Proteus mirabilis: effect on 
internalization by human renal epithelial cells and 
virulence in a mouse model of ascending urinary 
tract infection. Infect. Immun. 64: 5332–5340.  
MOBLEY, H.L.T., ISLAND, M.D., HAUSINGER, R.P. 
1995. Molecular biology of microbial ureases. 
Microbiol. Rev. 59: 451–480. 
MORGENSTEIN, R.M., SZOSTEK, B., RATHER, P.N. 2010. 
Regulation of gene expression during swarmer cell 
differentiation in Proteus mirabilis. FEMS 
Microbiol. Rev. 34: 753–763. 
MORYL, M. 2010. Investigations of biofilm formation 
by Proteus mirabilis and its sensitivity to 
antibacterial agents. Ph.D. Thesis. University of 
Lodz. (In Polish).  
MORYL, M., TORZEWSKA, A., RÓŻALSKI, A. 2008. 
Substances affecting Proteus mirabilis biofilm. In: 
Conference “Vaccines: Advances in plant and 
microbial biotechnology, infectious immunity and 
cancer therapy. Warsaw, SGGW Publisher. 179–
181. 
NIELUBOWICZ, G., MOBLEY, H.L.T. 2010. Host-
pathogen interactions in urinary tract infections. 
Nature Rev. Urology 7: 430–441.  
O' HARA, C., BRENNER, F.W., MILLER, J.M. 2000. 
Classification, identification, and clinical 
significance of Proteus, Providencia, and 
Morganella. Clin. Microbiol. Rev. 13: 534–546. 
OKIMOTO, N., HAYASHI, T., ISHIGA, M., NANBA, F., 
KISHIMOTO, M., YAGI, S., KURIHARA, T., ASOKA, 
N., TAMADA, S. 2010. Clinical features of Proteus 
mirabilis pneumonia. J. Infect. Chemother. 16: 
364–366. 
PALUSIAK, A., SIDORCZYK, Z. 2009. Serological 
characterization of the core region of 
lipopolysaccarides of rough Proteus sp. strains. 
Arch. Immunol. Ther. Exp. 57: 303–310. 
PALUSIAK, A., SIDORCZYK, Z. 2010. Characterization of 
epitope specificity of Proteus penneri 7. ABP. 57: 
529–532.  
PEARSON, M.M., MOBLEY, H.L.T. 2008. Repression 
motility during fimbrial expression; identification 
of 14 mrpJ gene paralogues in Proteus mirabilis. 
Mol. Microbiol. 69: 548–558. 
PERSON, M.M. et al. 2008. Complete genome sequence 
of uropathogenic Proteus mirabilis, a master of 
both adherence and motility. J. Bacteriol. 190: 
4027–4037. 
FOLIA BIOLOGICA ET OECOLOGICA 
RÓŻALSKI  ET AL.  16 
 
PHAN, V., BELAS, R., GILMORE, B.F., CERI, H. 2008.  
ZapA, a virulence factor in a rat model of Proteus 
mirabilis-induced acute and chronic prostatitis. 
Infect. Immun. 76: 4859–4864. 
PIECHOTA, J., PRYWER, J., TORZEWSKA, A. 2012. Ab 
initio prediction of structural and elastic properties 
of struvite: contribution to urinary stone research. 
Comput. Meth. Biochem. Engin. 15: 1329–1336. 
PRYWER, J., TORZEWSKA, A. 2009. Bacterially induced 
struvite growth from synthetic urine: experimental 
and theoretical characterization of crystal 
morphology. Cryst. Growth  Design. 9: 3538–3543.  
PRYWER, J., TORZEWSKA, A. 2010. Biomineralization 
of struvite crystals by Proteus mirabilis from 
artificial urine and their mesoscopic structure. 
Cryst. Res. Technol. 45: 1283–1289. 
PRYWER, J., TORZEWSKA, A. 2012. Effect of curcumin 
against Proteus mirabilis during crystallization of 
struvite form artificial urine. Evidence Base 
Complementary and Alternative Medicin. 862794: 
1–7.  
RADZIEJEWSKA-LEBRECHT, J., MAYER, H. 1989. The 
core region of Proteus mirabilis R110/1959 
lipopolysaccharide. Eur. J. Biochem. 183: 573–581. 
RAETZ, C.R., WHITFIELD, C. 2002. 
LIPOPOLYSACCHARIDE ENDOTOXIN. ANN. REV. 
BIOCHEM. 71: 635–700. 
RATHER, P.N. 2005. Swarmer cell differentiation in 
Proteus mirabilis. Environm. Microbiol. 7: 1065–
1073. 
ROCHA, S.P.D., ELIAS, W.P., CIANCIARULLO, A.M., 
MENEZES M.A., NARA, J.M., PIAZZA, R.F.M., 
SILVA, M.R.L., MOREIRA, C.G., PELAYO, J.S. 
2007a. Aggregative adherence of uropathogenic 
Proteus mirabilis to cultured epithelial cells. FEMS 
Immunol. Med. Microbiol. 51: 319–326.  
ROCHA, S.P.D., ELIAS, W.P., PELAYO, J.S. 2007b. 
Fimbriae of uropathogenic Proteus mirabilis. 
FEMS Immunol. Med. Microbiol. 51: 1–7. 
ROMANOWSKI, Z., KEMPISTY, P., PRYWER, J.,  
KRUKOWSKI, S., TORZEWSKA A. 2010. Density 
functional theory determination of structural and 
electronic properties of struvite: J. Phys. Chem. 
114: 7800–7808. 
RÓŻALSKI, A. 2002. Molecular basis of the 
pathogenicity of Proteus bacteria. Adv. Clin. Exp. 
Med. 11: 3–18. 
RÓŻALSKI, A. 2004. Lipopolysaccharide and others 
virulence factors of Proteus bacteria. Post. 
Mikrobiol. 43: 409–431. (In Polish). 
RÓŻALSKI, A. 2008. Lipopolysaccharide (LPS, 
endotoxin) of Proteus bacteria – chemical structure, 
serological specificity and the role in pathogenicity. 
Folia Biolog. Oecolog. 4: 5–24.  
RÓŻALSKI, A., DŁUGOŃSKA, H., KOTEŁKO, K. 1986. 
Cell invasiveness of Proteus mirabilis and Proteus 
vulgaris strains. Arch. Immunol. Ther. Exp. 34: 
505–511. 
RÓŻALSKI, A., KOTEŁKO, K. 1987. Hemolytic activity 
and invasiveness in strains of Proteus penneri. J. 
Clin. Microbiol. 25: 1094–1096. 
RÓŻALSKI, A., SIDORCZYK, Z., KOTEŁKO, K. 1997. 
Potential virulence factors of Proteus bacilli. 
Microbiol. Mol. Biol. Rev. 61: 65–89.  
RÓŻALSKI, A., STĄCZEK, P. 2010. Proteus. In: D. LIU, 
(ed.) Molecular detection of foodborne pathogens. 
CRS Press, Taylor and Francis Group. Boca Raton, 
p. 417–430.  
RÓŻALSKI, A., STĄCZEK, P. 2011. Proteus. In: 
Molecular detection of human bacterial pathogens. 
In: D. Liu (ed.), CRC Press, Taylor and Francis 
Group. Boca Raton, p. 981–996. 
RÓŻALSKI, A., TORZEWSKA, A., BARTODZIEJSKA B., 
BABICKA D., KWIL, I., PEREPELOV, A.V., 
KONDAKOVA, A.N., SENCHENKOVA, S.N., KNIREL, 
Y.A., VINOGRADOV, E.V. 2002. Chemical structure, 
antigenic specificity, the role in the pathogenicity of 
lipopolysaccharide (LPS, endotoxin) one the 
Proteus vulgaris bacteria’s example. Wiadomości 
Chemiczne. 56: 585–604. (In Polish).  
SCAVONE, P., UMPIERREZ, A., MASKELL, D.J., ZUNINO, 
P. 2011. Nasal immunization with attenuated 
Salmonella Thyphimurium expressing and MrpA-
TetC fusion protein significantly reduces Proteus 
mirabilis colonization in mouse urinary tract. J. 
Med. Microbiol. 60: 899–904.  
SCHLAPP, G., SCAVONE, P., ZUNINO, P., HARTEL, S. 
2011. Development of 3D architecture of 
uropathogenic Proteus mirabilis bath culture 
biofilms – A quantitative confocal microscopy 
approach. J. Microbiol. Meth. 87: 234–240. 
SIDORCZYK, Z., ZAHRINGER, U., RIETSCHEL, E.T. 1983. 
Chemical structure of the lipid A component of the 
lipopolysacharide of Proteus mirabilis Re mutant. 
Eur. J. Biochem. 137: 15–22.  
SOSA, V., ZUNINO, P. 2009. Effect of Ibicella lutea on 
uropathogenic Proteus mirabilis growth, virulence 
and biofilm formation. J. Infect. Dev. Ctries. 3: 
762–770.   
STAŃKOWSKA, D., CZERWONKA, G., RÓŻALSKA, S., 
GROSICKA, M., DZIADEK, J., KACA, W. 2012. 
Influence of quorum sensing signal molecules on 
biofilm formation in Proteus mirabilis O18. Folia 
Microbiol. 57: 53–60.  
STAŃKOWSKA, D., KWINKOWSKI, M., KACA, W. 2008. 
Quantification of Proteus mirabilis virulence 
factors and modulation by acylated homoserine 
lactones. J. Microbiol. Immunol. Infect. 41: 243–
253. 
FOLIA BIOLOGICA ET OECOLOGICA 
 
 
 
PROTEUS SP. – AN OPPORTUNISTIC BACTERIAL PATHOGEN  17 
 
STICKLER, D.J., 2008. Bacterial biofilms in patients 
with indwelling urinary catheters. Nature Clin. 
Pract. Urology. 5: 598–607. 
STICKLER, D.J., FENELEY, R.C.L. 2010. The 
encrustation and blockage of long-term indwelling 
bladder catheters: a way forward in prevention and 
control. Spinal Cord. 48: 784–790. 
SWIHART, K.G., WELCH, R.A. 1990. Cytotoxic activity 
of Proteus hemolysin HpmA. Infect. Immun. 58: 
1861–1869. 
TORZEWSKA, A., RÓŻALSKI, A. 2009. Studies on 
infection-induced urinary calculi formation in the 
presence of glycosaminoglycans. X Jubilee 
Conference "Molecular biology in diagnostic of 
infectious diseases and biotechnology, Warsaw 
University of Life Sciences - SGGW, 2009. 
Scientific materials, 179–182.  
TORZEWSKA, A., STĄCZEK, P., RÓŻALSKI, A. 2003. The 
crystallization of urine mineral components may 
depend on the chemical nature of Proteus 
endotoxin polysaccharides. J. Medical. Microbiol. 
52: 471–477. 
TORZEWSKA, A., ZIELIŃSKA, E., ŚWIDER, S., RÓŻALSKI, 
A. 2010. Influence of curcumin on Proteus 
mirabilis pathogenicity. Sepsis. 4: 276–277.  
UPHOFF, T.S., WELCH, R.A. 1990. Nucleotide 
sequencing of the Proteus mirabilis calcium 
independent hemolysin genes (hpmA and hpmB) 
reveals sequence similarity with Serratia 
marcescens hemolysin genes (shlA and shlB). J. 
Bacteriol. 172: 1206–1216. 
VERSTRAETEN, N., BREKANEN, K., DEBKUMARI, B., 
FAUVART, M., FRANSAER, J., VERMANT J., 
MICHIELS, J. 2008. Living on a surface: swarming 
and biofilm formation. Trends Microbiol. 16: 496–
506. 
VINOGRADOV, E. 2011. Structure of the core part of the 
lipopolysaccharide form Proteus mirabilis genomic 
strain HI4320. Biochemistry (Moscow). 76: 803–
807.  
VINOGRADOV, E.V., SIDORCZYK, Z., KNIREL, Y.A. 
2002. Structure of lipopolysaccharide core region of 
the genus Proteus. Aust. J. Chem. 55: 61–67. 
VINOGRADOV, E.V., THOMAS-OATES, E., BRADE, H., 
HOLST, O. 1994. Structural investigations of the 
lipopolysaccharide from Proteus mirabilis R45 
(Re-chemotype). J. End. Res. 1: 199–206.  
WANG, Q., TORZEWSKA, A., RUAN, X., WANG, X., 
RÓŻALSKI, A., SHAO, Z., GUO, X., FENG, L., WANG, 
L. 2010. Molecular and genetic analyses of the 
putative Proteus O-antigen gene locus. App. Env. 
Microbiol. 76: 5471–5480. 
WARREN, J.W. 1996. Clinical presentations and 
epidemiology of urinary tract infections. In: H.L.T. 
MOBLEY, J.W. WARREN (eds.) Urinary tract 
infections, molecular pathogenesis and clinical 
management. ASM Press, Washington DC, p. 2–28. 
WRAY, S.K., HULL, S.I., COOK, R.G., BARRISH, J., 
HULL, R.A. 1986. Identification and 
characterization of a uroepithelial cell adhesion 
from a uropathogenic isolate of Proteus mirabilis. 
Infect. Immun. 54: 43–49. 
ZUNINO, P., GEYMONT, L.,  ALLEN, A.G., LEGNANI-
FAJARDO, C., MASKELL, D.J. 2000. Virulence of 
Proteus mirabilis atf isogenic mutant is not 
impaired in a mouse model ascending urinary tract 
infection. FEMS Immunol. Med. Microbiol. 29: 
137–143. 
ZUNINO, P., PICCINI, C., LEGNIANI-FAJARDO, C. 1994. 
Flagellate and non flagellate Proteus mirabilis in 
the development of experimental urinary tract 
infection. Microb. Path. 16: 379–385. 
ZUNINO, P., SOSA, V., SHLAPP, G., ALLEN, A.G., 
PRESTON A., MASKELL, D.J. 2007. Mannose-
resistant Proteus-like and Proteus mirabilis 
fimbriae have specific and additive roles in 
P. mirabilis urinary tract infections. FEMS 
Immunol. Med. Microbiol. 51: 125–133. 
